The molecular basis of the specificity towards tumour cells by CAPs and defensins such as HBD-3, NaD1 and TPP3 [11, 12] is unclear but may be associated with morphological changes of plasma membranes upon tumour transformation to influence their robust growth, motility, invasion and metastasis, as opposed to normal cells [10]. The gene discussed is CAPS; the disease is neoplasm.